VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Brivoligide
Phase 2
Small molecule
A
Adynxx, Inc.
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Pain
1 trial
Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Knee Replacement in Patients With High PCS Scores
Withdrawn
·
A
Adynxx, Inc.
·
Phase 2
·
NCT03797612
Mastectomy
1 trial
Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores
Withdrawn
·
A
Adynxx, Inc.
·
Phase 2
·
NCT04104919
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Brivoligide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Brivoligide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Brivoligide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Adynxx, Inc. company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 2
[1]
Company
A
Adynxx, Inc.
Related News